0001639643-15-000002.txt : 20150424
0001639643-15-000002.hdr.sgml : 20150424
20150423192731
ACCESSION NUMBER: 0001639643-15-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 505
ITEM INFORMATION: 06b
ITEM INFORMATION: 4a5
FILED AS OF DATE: 20150424
DATE AS OF CHANGE: 20150423
EFFECTIVENESS DATE: 20150424
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kalytera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001639643
IRS NUMBER: 471374952
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-238608
FILM NUMBER: 15789656
BUSINESS ADDRESS:
STREET 1: 245 33RD STREET
CITY: HERMOSA BEACH
STATE: CA
ZIP: 90254
BUSINESS PHONE: 8888612008
MAIL ADDRESS:
STREET 1: 245 33RD STREET
CITY: HERMOSA BEACH
STATE: CA
ZIP: 90254
D
1
primary_doc.xml
X0707
D
LIVE
0001639643
Kalytera Therapeutics, Inc.
245 33RD STREET
HERMOSA BEACH
CA
CALIFORNIA
90254
8888612008
DELAWARE
None
None
Corporation
true
2014
Seth
Yakatan
245 33RD STREET
Hermosa Beach
CA
CALIFORNIA
90254
Executive Officer
Director
David
Stefansky
245 33RD STREET
Hermosa Beach
CA
CALIFORNIA
90254
Director
Other
Decline to Disclose
- 05
- 06b
- 4a5
false
2015-03-19
false
true
false
0
200000
200000
0
false
4
0
0
60000
true
A payment of $5,000 to the executive officer in April 2015
false
Kalytera Therapeutics, Inc.
/s/ Seth Yakatan
Seth Yakatan
Chief Executive Officer
2015-04-21